Loading clinical trials...
Loading clinical trials...
Pilot Phase 2 Study of Graviola (Guanabana) Leaves for The Treatment of Patients With Relapsed or Refractory Gastric Adenocarcinoma, Adenocarcinoma of Gastroesophageal Junction, Hepatocellular Carcinoma, Pancreatic Adenocarcinoma, Low Grade Lymphomas and Colorectal Adenocarcinoma
Conditions
Interventions
Tea Made of Graviola Leaves
Locations
1
Puerto Rico
Auxilio Mutuo Cancer Center
San Juan, Puerto Rico
Start Date
November 7, 2018
Primary Completion Date
November 1, 2023
Completion Date
November 1, 2023
Last Updated
February 26, 2021
NCT07485114
NCT06066138
NCT06811116
NCT06345508
NCT06901531
NCT04380545
Lead Sponsor
Auxilio Mutuo Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions